Status:
UNKNOWN
Target Planning for Placement of DBS-electrodes and Follow-up of the Clinical Efficacy of Stimulation
Lead Sponsor:
University of Zurich
Conditions:
Movement Disorders
Epilepsy
Eligibility:
All Genders
18-90 years
Brief Summary
Deep brain stimulation (DBS) has been established as therapy for severe forms of Parkinson's disease and other indications. A common target for stimulation is the subthalamic nucleus (STN). Neverthele...
Detailed Description
Deep brain stimulation (DBS) has been established as therapy for severe forms of Parkinson's disease and other indications. A common target for stimulation is the subthalamic nucleus (STN). Neverthele...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients fullfill all criteria for implantation of deep brain stimulation (DBS) electrodes
- Patients are able to give informed written consent
- Exclusion criteria:
- Patients do not their give informed written consent
Exclusion
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT01210781
Start Date
September 1 2009
End Date
December 1 2025
Last Update
December 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich, Neurosurgery
Zurich, Canton of Zurich, Switzerland, 8091